Shandong Boan Biotechnology Company., Limited. Class H (HK:6955) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Shandong Boan Biotechnology Co., Ltd. reported a significant revenue increase of 38.9% to RMB362.9 million for the first half of 2024, driven by strong sales growth of its products in China. The company also achieved a substantial 78.6% rise in gross profit, while managing to lower manufacturing costs due to increased production volume and improved manufacturing processes. Despite these gains, the company noted a decrease in R&D expenses as more projects moved into advanced clinical trials.
For further insights into HK:6955 stock, check out TipRanks’ Stock Analysis page.